On August 22, 2023, the U.S. Court of Appeals for the Federal Circuit issued yet another decision reinforcing what can only be described as the “lead compound” rule for challenging pharmaceutical and other chemical compound patents on the basis of obviousness.
The so-called “Lead Compound Analysis” is the primary legal framework for assessing chemical obviousness. Despite the USPTO Patent Trial and Appeal Board’s (PTAB) initial apparent.
On October 1st, Senior Party ToolGen Inc. filed its Motion to Exclude certain evidence presented by Junior Party the Broad Institute, Harvard University, and MIT (collectively, "Broad").
250 Pages Partial-Onset Seizures Market Survey by Fact MR, A Leading Business and Competitive Intelligence ProviderSeizures is a brain disorder characterized by a sudden, uncontrolled electrical disturbance in the brain. It involves changes in behavior, body movements or feelings, and consciousness levels of a patie.